Emmaus Life Sciences Announces Positive Top-Line Results of Its Phase 3 Clinical Trial For Sickle Cell DiseaseMarch 19, 2014 Read More
Emmaus Medical Announces Completion of All Patient Visits For Its Phase 3 Clinical Trial For Treatment of Sickle Cell DiseaseJanuary 07, 2014 Read More
Emmaus Life Sciences Cancels Stock Held By AFH Holding & Advisory and Amir HeshmatpourJuly 01, 2013 Read More
